Yesterday, Aug. 27, 2015, 98 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $287.50 to $3,256,000.00.

Highlighted Stocks Traded by Insiders:

Pacific Premier Bancorp (PPBI) - FREE Research Report

Nicholson E Allen, who is Executive V.P. & CFO at Pacific Premier Bancorp, bought 1,000 shares at $19.00 on Aug. 27, 2015. Following this transaction, the Executive V.P. & CFO owned 1,000 shares meaning that the stake was boosted by 100% with the 1,000-share transaction.

The shares most recently traded at $18.57, down $0.43, or 2.32% since the insider transaction. Historical insider transactions for Pacific Premier Bancorp go as follows:

  • 4-Week # shares bought: 6,550
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 8,050
  • 12-Week # shares sold: 10,000
  • 24-Week # shares bought: 13,250
  • 24-Week # shares sold: 10,000

The average volume for Pacific Premier Bancorp has been 89,800 shares per day over the past 30 days. Pacific Premier Bancorp has a market cap of $410.9 million and is part of the financial sector and banking industry. Shares are up 7.73% year-to-date as of the close of trading on Thursday.

Pacific Premier Bancorp, Inc. operates as the bank holding company for Pacific Premier Bank that provides banking services to professionals, real estate investors, and non-profit organizations in Southern California. The company has a P/E ratio of 19.1. Currently, there are 4 analysts who rate Pacific Premier Bancorp a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PPBI - FREE

TheStreet Quant Ratings

rates Pacific Premier Bancorp as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, solid stock price performance and good cash flow from operations. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

Pacific Premier Bancorp Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

DXP (DXPE) - FREE Research Report

Hamlin Todd, who is Sr. Vice President at DXP, bought 2,000 shares at $26.51 on Aug. 27, 2015. Following this transaction, the Sr. Vice President owned 24,619 shares meaning that the stake was boosted by 8.84% with the 2,000-share transaction.

The shares most recently traded at $28.12, up $1.61, or 5.73% since the insider transaction. Historical insider transactions for DXP go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 6,350
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 10,245
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 11,545

The average volume for DXP has been 144,600 shares per day over the past 30 days. DXP has a market cap of $377.9 million and is part of the services sector and wholesale industry. Shares are down 47.91% year-to-date as of the close of trading on Thursday.

DXP Enterprises, Inc. engages in distributing maintenance, repair, and operating (MRO) products, equipment, and services to industrial customers in the United States. It operates through three segments: Service Centers, Supply Chain Services, and Innovative Pumping Solutions. Currently, there are no analysts who rate DXP a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DXPE - FREE

TheStreet Quant Ratings

rates DXP as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, poor profit margins, generally high debt management risk and generally disappointing historical performance in the stock itself. Get the full

DXP Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

NxStage Medical (NXTM) - FREE Research Report

Turk Joseph E Jr, who is President at NxStage Medical, sold 2,000 shares at $18.25 on Aug. 27, 2015. Following this transaction, the President owned 109,163 shares meaning that the stake was reduced by 1.8% with the 2,000-share transaction.

The shares most recently traded at $17.32, down $0.93, or 5.37% since the insider transaction. Historical insider transactions for NxStage Medical go as follows:

  • 4-Week # shares bought: 10,150
  • 4-Week # shares sold: 10,335
  • 12-Week # shares bought: 10,150
  • 12-Week # shares sold: 19,595
  • 24-Week # shares bought: 10,150
  • 24-Week # shares sold: 28,475

The average volume for NxStage Medical has been 592,300 shares per day over the past 30 days. NxStage Medical has a market cap of $1.1 billion and is part of the health care sector and health services industry. Shares are down 1.28% year-to-date as of the close of trading on Thursday.

NxStage Medical, Inc., a medical device company, develops, manufactures, and markets products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures. Currently, there are 4 analysts who rate NxStage Medical a buy, 1 analyst rates it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on NXTM - FREE

TheStreet Quant Ratings

rates NxStage Medical as a

hold

. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full

NxStage Medical Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.